2 completed, 1 unknown. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Hydatidiform Mole: new trials by email Literature Review of Hydatidiform Mole trials Research Report on Hydatidiform Mole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Letrozole as a Prophylaxis From GTN for Complete Mole Patients Suction evacuation, Letrozole tablets - Gestational Trophoblastic Disease | Phase 2 / Phase 3 | Unknown | Zagazig University | 200 | 2020-06-01 | 2022-07-12 |
| Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors Laboratory Biomarker Analysis, Therapeutic Conventional Surgery - Complete Hydatidiform Mole, Non-Metastatic Gestational Trophoblastic Tumor | Phase 2 | Completed | Gynecologic Oncology Group | 64 | 2007-10-09 | 2017-08-24 |
| A Trial for Patients With Gestational Trophoblastic Disease Pemetrexed - Trophoblastic Neoplasms, Uterine Neoplasms | Phase 2 | Completed | Eli Lilly and Company | 50 | 2006-07-01 | 2007-08-09 |
Choriocarcinoma (1) · Gestational Trophoblastic Disease (1) · Trophoblastic Neoplasms (1) · Uterine Neoplasms (1)
Female Urogenital Diseases and Pregnancy Complications (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Germ Cell and Embryonal (3) · Pregnancy Complications (3) · Pregnancy Complications, Neoplastic (3) · Urogenital Diseases (3) · Gestational Trophoblastic Disease (2) · Trophoblastic Neoplasms (2) · Adenocarcinoma (1) · Carcinoma (1) · Female Urogenital Diseases (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1)
Letrozole (1) · Pemetrexed (1) · Vacuum Curettage (1)
Eli Lilly and Company (1) · Gynecologic Oncology Group (1) · Zagazig University (1)
United States (2) · Canada (1) · Egypt (1)
David Miller, MD (1) · Mohamed A Alabiad, MD (1) · Raymond Osborne (1)
U10CA027469 (1), U10CA180868 (1)